Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium.
Fernandez-Viladrich
P
P
Department of Infectious Diseases, Hospital de Bellvitge, University of Barcelona, Spain.
Corbella
X
X
Corral
L
L
Tubau
F
F
Mateu
A
A
D000150:Acinetobacter / Q000187:drug effects*; D000151:Acinetobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001927:Brain Diseases / Q000188:drug therapy / Q000382:microbiology; D015780:Carbapenems / Q000494:pharmacology*; D020806:Central Nervous System Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D002552:Cerebral Ventricles / Q000382:microbiology*; D003091:Colistin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004660:Encephalitis / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006801:Humans; D007276:Injections, Intraventricular; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D015780:Carbapenems; C004691:colistinmethanesulfonic acid; D003091:Colistin